Ascletis completes enrolment for US Phase II study of ASC30 in diabetes

Renalytix advances kidneyintelX.Dkd scale-up with laboratory expansion and CE submission

FDA expands approval of Sanofi's Tzield for early-stage type 1 diabetes in young children

EKF Diagnostics acquires Beep Insights technology to expand sports performance offering

Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval

Lupin's Dapagliflozin Tablets launched in US market

Eli Lilly launches Foundayo weight‑loss pill in the US

Lupin's Dapagliflozin Tablets receive US regulatory approval

Caliway to present preclinical data on CBL-514 in combination with GLP-1R therapy at ADA 2026 Scientific Sessions

Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval

Innovent and Ollin Biosciences report IBI324 study data in wAMD and DME

Amgen reports Repatha (evolocumab) cuts risk of first major CV events by 31% in high-risk patients without known significant atherosclerosis

AROA Biosurgery completes Symphony trial in patients with diabetic foot ulcers

Novo Nordisk's Awiqli once-weekly basal insulin treatment approved by US FDA

Kodiak Sciences reports positive Phase 3 results for Zenkuda in diabetic retinopathy